Synthesis of tritium??labeled levetiracetam ((2S)??2??(2??oxopyrrolidin??1??yl) butanamide) with high specific activity

S Hildenbrand, Y Baqi, CE Müller

文献索引：Hildenbrand, Simone; Baqi, Younis; Mueller, Christa E. Journal of Labelled Compounds and Radiopharmaceuticals, 2012 , vol. 55, # 1 p. 48 - 51

全文：HTML全文

被引用次数: 2

摘要

Levetiracetam (1;(2S)-2-(2-oxopyrrolidin-1-yl) butanamide, KeppraW) is a pyrrolidone drug widely used in antiepileptic therapy. Since its approval in the USA in 1999, it has become one of the most successful therapeutics of the newer classes of antiepileptic drugs (AED). Several beneficial properties including potent antiepileptogenic effects, absence of severe adverse effects, and a low potential for drug interactions1, 2 have indicated that ...